This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Insights & Events

Filter

Content Type

Format

Service

Industry

Date

Showing 1-12 of 334 Search Results

Life Sciences

Life sciences considerations for investment treaty disputes
- Articles
- August 26, 2024
Forensic Accounting

65 CRA consultants recognized in Who’s Who Legal: Consulting Experts & Thought Leaders 2024
- Awards & Recognitions
- August 23, 2024
Life Sciences

Antibody-drug conjugates: where are we now, where is it heading, and how can you get ahead of the opportunities and challenges with key stakeholders?
- CRA Insights
- August 21, 2024
Life Sciences

The end of high drug prices? Exploring the potential and limits of PDABs
- CRA Insights
- July 2024
Life Sciences

Ethics of artificial intelligence in the life sciences industry
- Podcasts
- July 9, 2024
Life Sciences

ASCO 2024 review: The benefits and barriers of biomarkers in oncology
- CRA Insights
- June 25, 2024
Life Sciences

Quantifying public and private investment in European biopharmaceutical research and development
- Articles
- June 2024
Analytics in Life Sciences

Uptake of advanced therapies in psoriasis and psoriatic arthritis
- Infographics
- June 19, 2024
Life Sciences

Payer value demonstration—The evolving role of health economics and outcomes research (HEOR)
- CRA Insights
- June 2024
Life Sciences

Time from EMA approval to CT outcome for first indication vs. ASMR
- Infographics
- May 29, 2024
Life Sciences Litigation

Best practices in the use of damages experts in complex commercial arbitrations
- Books
- May 22, 2024
Life Sciences

Impact of Medicare Price “Negotiation” Program on small and large molecule medicines
- Reports
- May 2024